Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Change in Accured Expenses (2020 - 2025)

Core Scientific (CORZW) has disclosed Change in Accured Expenses for 6 consecutive years, with -$42.3 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 190.56% to -$42.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$17.4 million through Dec 2025, down 1025.53% year-over-year, with the annual reading at -$17.4 million for FY2025, 1025.53% down from the prior year.
  • Change in Accured Expenses hit -$42.3 million in Q4 2025 for Core Scientific, down from $34.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $117.4 million in Q4 2023 to a low of -$42.3 million in Q4 2025.
  • Historically, Change in Accured Expenses has averaged $9.4 million across 5 years, with a median of $3.3 million in 2021.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 9563650.0% in 2021 and later plummeted 1042.49% in 2024.
  • Year by year, Change in Accured Expenses stood at $38.3 million in 2021, then plummeted by 54.33% to $17.5 million in 2022, then soared by 571.9% to $117.4 million in 2023, then tumbled by 60.17% to $46.8 million in 2024, then plummeted by 190.56% to -$42.3 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CORZW at -$42.3 million in Q4 2025, $34.7 million in Q3 2025, and -$12.5 million in Q2 2025.